InvestorsHub Logo
Followers 556
Posts 17586
Boards Moderated 4
Alias Born 01/02/2005

Re: None

Sunday, 11/25/2007 7:59:23 PM

Sunday, November 25, 2007 7:59:23 PM

Post# of 26
Here are the impressive biographies for the SHPI management and Board of Directors:

Jeff Soinski, President & CEO, and Director

Mr. Soinski brings 23 years of general management, business development and marketing experience to SHPI, including several years as the President and CEO of ViroTex Corporation (“ViroTex”), a venture-backed pharmaceutical company focused on the development and commercialization of proprietary drug delivery systems. Mr. Soinski merged ViroTex into Atrix Laboratories, Inc. (NASDAQ: ATRX) in 1998, and continued working with Atrix on a transitional basis through 1999. Prior to joining SHPI, he was the Managing Partner and CEO of Mad Dogs & Englishmen, a marketing communications firm with offices in New York and San Francisco. Mr. Soinski has a BA degree from Dartmouth College.

Guy Jordan, Ph.D., Chairman of the Board

Dr. Jordan brings a wealth of senior management healthcare experience to SHPI, with a strong focus in the areas of vascular disease and oncology. Dr. Jordan recently retired as Group President for C.R. Bard, Inc. with global operating responsibility for their oncology businesses, geographic responsibility for Canada, Australia, Latin America and Asia Pacific, and functional responsibility for all of Bard’s research and development. Prior to joining C.R. Bard in 1986, Dr. Jordan held senior product development positions at American Cyanamid. Dr. Jordan has a Ph.D. degree from Georgetown University and an MBA from Fairleigh Dickinson University.

Donald Solomon, Ph.D., COO, CTO, Vice President, and Director

Dr. Solomon has over 25 years of medical product experience in research, product development, engineering and manufacturing. Prior to joining SHPI, Dr. Solomon was the Vice President of Research and Development at Johnson & Johnson Medical – Vascular Access. Prior to that he spent 14 years at Becton Dickinson (“BD”), and held positions as Worldwide Director of R&D for BD Pharmaceutical Systems Division based in France, and Director of R&D for Biocompatible Polymer Development at the BD Infusion Therapy Division. Dr. Solomon holds 50 patents and is the author of 52 scientific publications. He received Masters and Ph.D. degrees from Case Institute of Technology at Case Western Reserve University.

Paul Evans, Vice President, Business Development, General Counsel and Secretary

Mr. Evans is a registered patent attorney and brings a wide range of intellectual property and corporate legal experience to SHPI, having previously served as Vice President, General Counsel for an R&D company, and as a patent attorney with the law firm of Snow, Christensen & Martineau. Mr. Evans manages our intellectual property portfolio and corporate legal matters, and is extensivel involved in business development efforts. Prior to earning his law degree, Mr. Evans worked as a Project/Design Engineer for Morton International (now Autoliv). He holds JD, MBA and BS degrees from the University of Utah.

David Green, Chief Financial Officer, and Treasurer

Mr. Green brings 13 years of investment banking and financial advisory experience to SHPI. Most recently, Mr. Green was a Managing Director and head of the life sciences practice in the San Francisco office of Duff & Phelps. Mr. Green was also a Director in the mergers and acquisitions group and head of the fairness opinion practice at Ernst & Young in Palo Alto, California. Mr. Green has a BS degree in chemistry from the State University of New York at Brockport and an MBA in finance from the University of Rochester.

David Jahns, Director

Mr. Jahns is a General Partner and principal of Galen Partners. Since joining Galen in 1993, Mr. Jahns has been responsible for making and managing successful investments in several of the firm’s portfolio companies. He is an experienced board member and currently serves on the boards of DAOU Systems, Inc. and several of Galen’s privately held portfolio companies. Prior to joining Galen, Mr. Jahns worked in the Corporate Finance Division at Smith Barney. Mr. Jahns has an MBA degree from the J. L. Kellogg Graduate School of Management at Northwestern University and a BA degree from Colgate University.

Stuart Randle, Director

Mr. Randle is a highly experienced healthcare executive with over 20 years of operating experience. He is currently Chief Executive Officer of GI Dynamics, a medical device company focused on the treatment of obesity. From 1998 to 2001, Mr. Randle was the President and CEO of ACT Medical, Inc., a leading company providing outsourcing services to the medical device, biotech and diagnostic industries. He merged ACT Medical with MedSource Technologies in 2001. Prior to ACT Medical, Mr. Randle was President, Northeast Region, for Allegiance Corporation, a $5 billion medical products distribution and manufacturing company. He is also the past President, New England Region, for Baxter Healthcare Corporation. Mr. Randle has an MBA degree from the J. L. Kellogg Graduate School of Management at Northwestern University and a BS degree from Cornell University.

Steve Shapiro, Director

Mr. Shapiro has over 30 years of relevant medical device and equipment industry experience, including executive positions at Union Carbide Clinical Diagnostics and Becton Dickinson, where he was Director of Advanced R&D and New Business Development. In 1982, he joined The Wilkerson Group, a leading management consultancy to pharmaceutical, medical device, and diagnostic companies. Mr. Shapiro was Managing Director of The Wilkerson Group at the time of its acquisition by IBM in 1996. In 1999, Mr. Shapiro left The Wilkerson Group (now IBM Healthcare Consulting) to focus on sourcing and evaluating investments for two premier healthcare venture capital firms, including Galen Partners. Mr. Shapiro has a BS degree from MIT and an MS degree in biomedical engineering from the University of California, Berkley.

Bob Walker, Director

Mr. Walker is the past President of the IHC Affiliated Services Division of Intermountain Healthcare, a regional hospital company. He is also former Chairman of the Board of AmeriNet, Inc., a national group purchasing organization for hospitals, clinics, detox/drug centers, emergency, nursing homes, and other healthcare institutions. Mr. Walker is a member of the American Hospital Association and the Hospital Financial Management Association. He has a BS degree in Business Administration from the University of Utah.

Mike
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.